Security National Bank of So Dak’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-6,300
Closed -$209K 99
2023
Q3
$209K Hold
6,300
0.15% 94
2023
Q2
$231K Buy
+6,300
New +$245K 0.17% 91
2022
Q4
$327K Hold
6,385
0.24% 78
2022
Q3
$279K Hold
6,385
0.25% 77
2022
Q2
$335K Sell
6,385
-15
-0.2% -$764 0.28% 72
2022
Q1
$331K Buy
6,400
+2,500
+64% +$130K 0.23% 78
2021
Q4
$230K Buy
+3,900
New +$193K 0.15% 95
2021
Q3
Sell
-7,200
Closed -$282K 111
2021
Q2
$282K Buy
+7,200
New +$280K 0.22% 80
2015
Q2
Sell
-6,106
Closed -$202K 68
2015
Q1
$202K Buy
+6,106
New +$194K 0.32% 65
2013
Q3
Sell
-8,972
Closed -$238K 71
2013
Q2
$238K Buy
+8,972
New +$248K 0.41% 69

Other funds holding PFE

Security National Bank of So Dak's PFE Position: Q4 2023 in Review

Security National Bank of So Dak sold out of Pfizer (PFE) in Q4 2023, closing a stake of 6,300 shares — an estimated $209K sold.

Security National Bank of So Dak first reported a position in PFE in Q2 2013 and held it in 10 quarters. The position peaked at $335K in Q2 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • Security National Bank of So Dak reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • Security National Bank of So Dak sold 6,300 Pfizer shares in Q4 2023, an estimated $209K.
  • Security National Bank of So Dak first reported a position in Pfizer in Q2 2013 and held it in 10 quarters.
  • Security National Bank of So Dak's Pfizer position peaked at $335K in Q2 2022.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Security National Bank of So Dak's 13F filing for Q4 2023, filed 16 Feb 2024.